Business Description
Wanbangde Pharmaceutical Holding Group Co Ltd
NAICS : 212299
SIC : 3334
ISIN : CNE000001P94
Share Class Description:
SZSE:002082: Class ACompare
Compare
Traded in other countries / regions
002082.China IPO Date
2006-11-20Description
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.19 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | 11.37 | |||||
| Interest Coverage | 2.65 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 2.3 | |||||
| Beneish M-Score | -2.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -52 | |||||
| 3-Year EBITDA Growth Rate | -30.6 | |||||
| 3-Year EPS without NRI Growth Rate | -33.6 | |||||
| 3-Year FCF Growth Rate | 21.3 | |||||
| 3-Year Book Growth Rate | 0.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 89.76 | |||||
| 9-Day RSI | 75 | |||||
| 14-Day RSI | 65.79 | |||||
| 6-1 Month Momentum % | -24.89 | |||||
| 12-1 Month Momentum % | -34.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.34 | |||||
| Quick Ratio | 1.17 | |||||
| Cash Ratio | 0.13 | |||||
| Days Inventory | 106.46 | |||||
| Days Sales Outstanding | 224.07 | |||||
| Days Payable | 112.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.29 | |||||
| Dividend Payout Ratio | 0.92 | |||||
| 3-Year Dividend Growth Rate | -7.2 | |||||
| Forward Dividend Yield % | 2.29 | |||||
| 5-Year Yield-on-Cost % | 2.29 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | -2.02 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.29 | |||||
| Operating Margin % | 7.78 | |||||
| Net Margin % | 3.2 | |||||
| FCF Margin % | -1.25 | |||||
| ROE % | 1.91 | |||||
| ROA % | 1.16 | |||||
| ROIC % | 2.44 | |||||
| ROC (Joel Greenblatt) % | 3.57 | |||||
| ROCE % | 2.97 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 64.51 | |||||
| PE Ratio without NRI | 40.69 | |||||
| Shiller PE Ratio | 14.68 | |||||
| PS Ratio | 2.06 | |||||
| PB Ratio | 1.21 | |||||
| Price-to-Tangible-Book | 1.56 | |||||
| Price-to-Operating-Cash-Flow | 24.05 | |||||
| EV-to-EBIT | 45.42 | |||||
| EV-to-EBITDA | 45.42 | |||||
| EV-to-Revenue | 2.56 | |||||
| EV-to-FCF | -204.16 | |||||
| Price-to-Median-PS-Value | 5.59 | |||||
| Price-to-Graham-Number | 1.68 | |||||
| Price-to-Net-Current-Asset-Value | 16.59 | |||||
| Earnings Yield (Greenblatt) % | 2.2 | |||||
| FCF Yield % | -0.6 | |||||
| Forward Rate of Return (Yacktman) % | -30.57 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wanbangde Pharmaceutical Holding Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,585.883 | ||
| EPS (TTM) (Â¥) | 0.082 | ||
| Beta | 1.55 | ||
| Volatility % | 25.93 | ||
| 14-Day RSI | 65.79 | ||
| 14-Day ATR (Â¥) | 0.186739 | ||
| 20-Day SMA (Â¥) | 4.7005 | ||
| 12-1 Month Momentum % | -34.6 | ||
| 52-Week Range (Â¥) | 3.7 - 7.97 | ||
| Shares Outstanding (Mil) | 616.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wanbangde Pharmaceutical Holding Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wanbangde Pharmaceutical Holding Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Wanbangde Pharmaceutical Holding Group Co Ltd Frequently Asked Questions
What is Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082)'s stock price today?
The current price of SZSE:002082 is ¥5.31. The 52 week high of SZSE:002082 is ¥7.97 and 52 week low is ¥3.70.
When is next earnings date of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082)?
The next earnings date of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) is .
Does Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) pay dividends? If so, how much?
The Dividend Yield %  of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) is 2.29% (As of Today), Highest Dividend Payout Ratio of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) was 0.93. The lowest was 0.2. And the median was 0.65. The  Forward Dividend Yield % of Wanbangde Pharmaceutical Holding Group Co Ltd(SZSE:002082) is 2.29%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers